NCT07620795

Brief Summary

Cervical cancer is a highly preventable public health issue that significantly impacts women's quality of life. Although effective screening programs such as Human Papilloma Virus (HPV) testing and Pap-smears are widely available, women's participation in these early detection services often remains limited. The primary barriers to screening attendance include insufficient education, lack of information, negative beliefs, psychosocial or cultural factors, and misconceptions regarding gynecological examinations. To improve screening uptake, health interventions must focus not only on increasing knowledge but also on promoting correct beliefs and positive attitudes toward testing. Web-based health education serves as an effective method to overcome barriers such as cost, transportation difficulties, and geographical limitations, allowing wider access to healthcare guidance. This study aims to evaluate the effects of a specialized web-based educational intervention on women's attitudes and beliefs regarding the HPV test. The research is designed as a randomized controlled trial with a pre-test and post-test design. Participants will be assigned to either an intervention group or a control group. The intervention group will receive structured health education through a dedicated web platform, while the control group will receive routine standard follow-up. Data will be gathered using a specific attitude and belief scale before and after the application to measure the intervention's impact.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Jul 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
29 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

2 months

First QC Date

May 20, 2026

Last Update Submit

May 27, 2026

Conditions

Keywords

HPV TestingHealth EducationWeb-based learningAttitudes and Beliefs

Outcome Measures

Primary Outcomes (4)

  • Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Personal Barriers Subscale

    This subscale consists of 7 items (items 1-7) assessing personal barriers, stigma, and shame related to HPV testing. Scores range from 7 to 49. A higher score indicates a higher level of perceived personal barriers, meaning a less favorable attitude toward HPV testing.

    Baseline and 12 weeks post-intervention

  • Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Social Norms Subscale

    This subscale consists of 4 items (items 8-11) assessing the influence of friends, partners, family, and social media on HPV testing. Scores range from 4 to 28. A higher score indicates higher negative social pressure/barriers, meaning a lower level of favorable attitudes and beliefs

    Baseline and 12 weeks post-intervention

  • Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Trust Subscale

    This subscale consists of 6 items (items 12-17) assessing trust in the healthcare system, accuracy of HPV testing, and medical procedures. Scores range from 6 to 42. A higher score indicates higher levels of perceived benefit, confidence, and trust toward HPV testing.

    Baseline and 12 weeks post-intervention

  • Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Concerns Subscale

    This subscale consists of 3 items (items 18-20) assessing concerns and worries related to the process and outcomes of HPV testing. Scores range from 3 to 21. A higher score indicates higher levels of concerns/negative attitudes toward HPV testing.

    Baseline and 12 weeks post-intervention

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants in this group will receive access to the web-based health education platform developed for the study.

Behavioral: Web-Based Health Education

control group

NO INTERVENTION

Participants in this group will receive standard routine follow-up during the study. After the completion of the study data collection, the web-based health education platform will also be made accessible to this group.

Interventions

Participants in the intervention group will receive health education through a specially designed web-based platform containing 11 presentations in total (8 PowerPoint presentations, 1 animation video explaining how the HPV test is performed, and 1 researcher-led instructional video demonstrating self-vulvar examination on a model). Participants will also be provided with educational brochures and magnets. For participants who do not view the presentations, weekly reminder text messages will be sent to encourage platform login and module completion.

Intervention Group

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Having no prior clinical diagnosis of cervical cancer
  • Being between 18 and 60 years of age
  • Having active access to the internet
  • Being literate at a level sufficient to read and understand the questionnaire forms
  • Being capable of effectively navigating and using a web browser
  • Being registered as a patient at Sakarya Akyazı No. 3 Family Health Center
  • Volunteering to participate in the study and providing informed consent

You may not qualify if:

  • Withdrawing from the study voluntarily at any stage
  • Failing to watch the mandatory educational videos on the platform
  • Submitting incomplete or incorrect responses to the data collection tools
  • Lacking active internet access or proper web browser usage skills
  • Criteria for Study Discontinuation / Drop-out:
  • Participant's request to withdraw from the study
  • Failure to respond to or complete the data collection tools
  • Not using or logging into the web application for more than 2 consecutive weeks during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Uterine Cervical NeoplasmsHealth EducationBehavior

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Study Officials

  • ZEKİYE TURAN, Phd, Associate Professor

    Sakarya University Faculty of Health Sciences

    STUDY CHAIR

Central Study Contacts

MERVE İÇÖZ, Phd Student, Msc Midwife

CONTACT

ZEKİYE TURAN, Phd, Associate Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be stratified by age and randomly assigned using block randomization to either the intervention group, which receives web-based health education, or the control group, which receives standard follow-up without education.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Phd Candidate, Department of Midwifery

Study Record Dates

First Submitted

May 20, 2026

First Posted

June 2, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared to ensure and maintain participant confidentiality in accordance with the institutional ethics committee approval and local data protection regulations.